Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Progyny, Inc. is a leading fertility benefits management company that provides comprehensive fertility solutions to employers and their employees across the United States. The company's unique approach includes a high-touch service model and a proprietary network of fertility specialists, setting it apart in the rapidly growing fertility benefits market.
Progyny generates revenue primarily through employer contracts for fertility benefits management, which includes access to a network of fertility specialists and related services. The company benefits from pricing power due to its differentiated service offering and established relationships with employers, allowing it to command higher fees compared to traditional health plans.
Growth in employer adoption of fertility benefits programs
Changes in healthcare regulations affecting fertility treatments
Expansion of the company's network of fertility specialists
Trends in employee demand for fertility services
Potential regulatory changes impacting fertility treatment coverage
Technological disruption in healthcare delivery models
Emergence of new competitors offering similar fertility benefits solutions
Pressure from traditional health insurers to enhance their fertility offerings
Low liquidity risk due to strong cash flow generation
Minimal financial risk from low debt levels
moderate - The demand for fertility services is somewhat insulated from economic downturns, but overall consumer spending and employer benefits budgets can impact growth.
Low - Progyny's business model is not significantly affected by interest rates, as it does not rely heavily on debt financing and operates on a fee-for-service basis.
minimal - The company has a low debt-to-equity ratio (0.06), indicating minimal reliance on credit.
growth - Investors are likely attracted to Progyny due to its strong revenue growth and expanding market presence.
moderate - The stock has shown historical volatility, but its recent performance indicates a positive trend.